In 2022, "speed up and expansion" became the key word for the centralized procurement of high value medical consumables. At present, the centralized procurement of high value medical consumables in China is gradually spreading, and national centralized procurement, alliance centralized procurement, and provincial centralized procurement are vigorously promoted. The centralized purchase rules have been continuously innovated and improved, the centralized purchase model has become increasingly mature, the range of procurement varieties has continued to expand, and the price reduction of selected products has tended to be moderate. At the same time, the centralized procurement of high value medical consumables has expanded to the field of consumer medical care, and the selected products are mostly products of domestic leading enterprises. This means that domestic enterprises will accelerate their efforts to seize the market share of foreign enterprises, and domestic substitution is expected to accelerate.

Gradually spread the centralized procurement of consumables

National centralized procurement: "Orthopedics" dust settles, "stent" expires and continues

On October 16, 2020, the National Organization's Joint Procurement Office for High Value Medical Consumables issued the "National Organization's Document for Centralized Procurement of Coronary Stents (GH-HD2020-1)", which launched the "first shot" in the centralized procurement of high value medical consumables in China. On June 21, 2021, the second batch of national organized high value medical consumables centralized procurement was launched in Tianjin, focusing on artificial joints and orthopedic high value medical consumables.

On July 11, 2022, the "National Organization and Orthopedics spine consumables centralized procurement announcement (No. 1)" was released, which is the third batch of national organization and high value medical consumables centralized procurement launched after coronary stents and artificial joints. According to the needs of cervical spine and thoracolumbar surgery, this centralized procurement covers 5 orthopedic spinal consumables such as cervical spine fixation and fusion surgery and thoracolumbar spine fixation and fusion surgery, forming 14 product system categories. There are 152 enterprises to be selected, with an average price reduction of 84% for the proposed products. It is estimated that the annual cost savings will be 26 billion yuan.

On September 9, 2022, the Announcement on Continued Procurement after the Expiration of the National Organization Agreement on Centralized Procurement of Coronary Stents (No. 1) was released. After the expiration of the National Organization Agreement on Centralized Procurement of Coronary Stents, continued procurement began, with a total of 3696 medical institutions participating in the reporting, an increase of 1288 compared to the previous round; The total procurement demand in the first year was approximately 1865000 units, an increase of approximately 530000 units compared to the previous round of demand. This procurement of coronary stents is the first renewal of the national centralized procurement of high value medical consumables, exploring procurement rules applicable to the continuation after the expiration of the centralized procurement agreement, and creating a "national template" for the continuation work after the expiration of the local centralized procurement.

Alliance collection: "electrophysiology" plus "dental implant" first included

According to the statistical data of Zhongcheng Digital Science and Technology Department, in 2022, China launched a total of 14 provincial alliance procurement of high value medical consumables, covering 13 types of high value medical consumables such as cardiac pacemakers, intraocular lenses, and orthopedic trauma.

"Continuation" and "innovation" are the key words for the centralized procurement of high value medical consumables in the provincial alliance in 2022. Popular varieties such as intraocular lenses, orthopedic consumables, and coronary intervention products that were intensively purchased in 2021 continued to be intensively purchased in the provincial alliance in 2022, but both the coverage area and the frequency of centralized procurement decreased compared to 2021. At the same time, in 2022, the provincial alliance was also continuously exploring new areas of centralized procurement models, and oral consumables such as orthodontic brackets and dental implant systems were included in the scope of centralized procurement for the first time. In addition, high value medical consumables such as hemodialysis, cardiac interventional electrophysiology, and cochlear implants were also collected in the first provincial alliance in 2022.

From the perspective of the scope of centralized procurement of high value medical consumables by the Inter Provincial Alliance, the number of areas covered by oral implant systems, cardiac interventional electrophysiology, and spring coils ranks among the top three.

Single provincial centralized procurement: forge ahead, ranking first in the number of projects in Anhui